Company registration number SC543005 (Scotland)
THERMA-CHEM INTERNATIONAL LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025
PAGES FOR FILING WITH REGISTRAR
THERMA-CHEM INTERNATIONAL LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 4
THERMA-CHEM INTERNATIONAL LIMITED
BALANCE SHEET
AS AT 31 AUGUST 2025
31 August 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
3
-
0
399
Current assets
Debtors
4
83,267
366,509
Cash at bank and in hand
508,581
442,992
591,848
809,501
Creditors: amounts falling due within one year
5
(52,927)
(173,207)
Net current assets
538,921
636,294
Total assets less current liabilities
538,921
636,693
Creditors: amounts falling due after more than one year
6
(513,578)
(513,638)
Net assets
25,343
123,055
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
25,243
122,955
Total equity
25,343
123,055

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 18 May 2026 and are signed on its behalf by:
Mr R A Semple
Director
Company Registration No. SC543005
THERMA-CHEM INTERNATIONAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025
- 2 -
1
Accounting policies
Company information

Therma-Chem International Limited is a private company limited by shares incorporated in Scotland. The registered office is Campbell Dallas, Titanium 1, King's Inch Place, Renfrew, PA4 8WF. The principle place of business is 52 Crossgates, Bellshill, ML4 2EE.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures and fittings
25% straight line
Computers
33% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

1.5
Cash at bank and in hand

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.6
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

THERMA-CHEM INTERNATIONAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
1
Accounting policies
(Continued)
- 3 -

Changes in the fair value of derivatives that are designated and qualify as fair value hedges are recognised in profit or loss immediately, together with any changes in the fair value of the hedged asset or liability that are attributable to the hedged risk.

1.7
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.8
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.9
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
1
1
3
Tangible fixed assets
Fixtures and fittings
Computers
Total
£
£
£
Cost
At 1 September 2024 and 31 August 2025
547
1,598
2,145
Depreciation and impairment
At 1 September 2024
547
1,199
1,746
Depreciation charged in the year
-
0
399
399
At 31 August 2025
547
1,598
2,145
Carrying amount
At 31 August 2025
-
0
-
0
-
0
At 31 August 2024
-
0
399
399
THERMA-CHEM INTERNATIONAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
- 4 -
4
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
-
0
365,489
Other debtors
83,267
1,020
83,267
366,509
5
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
47,104
57,811
Taxation and social security
3,408
38,396
Other creditors
2,415
77,000
52,927
173,207
6
Creditors: amounts falling due after more than one year
2025
2024
£
£
Other creditors
513,578
513,638
7
Related party transactions

The following amounts were outstanding at the reporting end date:

2025
2024
Amounts due to related parties
£
£
Key management personnel
513,578
513,638

These balances are unsecured, interest free and have no formal terms of repayment.

2025-08-312024-09-01falsefalsefalse18 May 2026CCH SoftwareCCH Accounts Production 2026.100No description of principal activityMr R A SempleMrs H SempleMr S SempleSC5430052024-09-012025-08-31SC5430052025-08-31SC5430052024-08-31SC543005core:FurnitureFittings2025-08-31SC543005core:ComputerEquipment2025-08-31SC543005core:FurnitureFittings2024-08-31SC543005core:ComputerEquipment2024-08-31SC543005core:CurrentFinancialInstrumentscore:WithinOneYear2025-08-31SC543005core:CurrentFinancialInstrumentscore:WithinOneYear2024-08-31SC543005core:Non-currentFinancialInstrumentscore:AfterOneYear2025-08-31SC543005core:Non-currentFinancialInstrumentscore:AfterOneYear2024-08-31SC543005core:CurrentFinancialInstruments2025-08-31SC543005core:CurrentFinancialInstruments2024-08-31SC543005core:ShareCapital2025-08-31SC543005core:ShareCapital2024-08-31SC543005core:RetainedEarningsAccumulatedLosses2025-08-31SC543005core:RetainedEarningsAccumulatedLosses2024-08-31SC543005bus:Director12024-09-012025-08-31SC543005core:FurnitureFittings2024-09-012025-08-31SC543005core:ComputerEquipment2024-09-012025-08-31SC5430052023-09-012024-08-31SC543005core:FurnitureFittings2024-08-31SC543005core:ComputerEquipment2024-08-31SC5430052024-08-31SC543005core:Non-currentFinancialInstruments2025-08-31SC543005core:Non-currentFinancialInstruments2024-08-31SC543005core:KeyManagementPersonnel2025-08-31SC543005core:KeyManagementPersonnel2024-08-31SC543005bus:PrivateLimitedCompanyLtd2024-09-012025-08-31SC543005bus:FRS1022024-09-012025-08-31SC543005bus:AuditExemptWithAccountantsReport2024-09-012025-08-31SC543005bus:Director22024-09-012025-08-31SC543005bus:Director32024-09-012025-08-31SC543005bus:SmallCompaniesRegimeForAccounts2024-09-012025-08-31SC543005bus:FullAccounts2024-09-012025-08-31xbrli:purexbrli:sharesiso4217:GBP